Works matching IS 10837159 AND DT 2023 AND VI 28 AND IP 3
Results: 20
Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. 230, doi. 10.1093/oncolo/oyad007
- By:
- Publication type:
- Article
Association Between Medication Use in Older Women with Early-Stage Operable Primary Breast Cancer and Decision Regarding Primary Treatment.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. e128, doi. 10.1093/oncolo/oyac278
- By:
- Publication type:
- Article
Evidence Regarding Pharmacogenetics in Pain Management and Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. 189, doi. 10.1093/oncolo/oyac277
- By:
- Publication type:
- Article
Phase II Trials of Iniparib (BSI-201) in Combination with Gemcitabine and Carboplatin in Patients with Recurrent Ovarian Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. 252, doi. 10.1093/oncolo/oyac275
- By:
- Publication type:
- Article
HiJAKing Immunotherapy-Resistant Melanoma for a Cure.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. 196, doi. 10.1093/oncolo/oyac270
- By:
- Publication type:
- Article
Prevalence and Associations of Beta2-Microglobulin Mutations in MSI-H/dMMR Cancers.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. e136, doi. 10.1093/oncolo/oyac268
- By:
- Publication type:
- Article
BRAF V600E and RNF43 Co-mutations Predict Patient Outcomes with Targeted Therapies in Real-World Cases of Colorectal Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. e171, doi. 10.1093/oncolo/oyac265
- By:
- Publication type:
- Article
Trends, Changes, and Disruptions: The Fragile Economics of Cancer Treatments.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. 193, doi. 10.1093/oncolo/oyac258
- By:
- Publication type:
- Article
Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune Response in Patients Receiving Anti–Cancer Treatment.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. e145, doi. 10.1093/oncolo/oyac257
- By:
- Publication type:
- Article
Clinical Treatment Guidelines for Tafasitamab plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. 199, doi. 10.1093/oncolo/oyac256
- By:
- Publication type:
- Article
Tivozanib in Patients with Advanced Renal Cell Carcinoma Previously Treated with Axitinib: Subgroup Analysis from TIVO-3.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. e167, doi. 10.1093/oncolo/oyac255
- By:
- Publication type:
- Article
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Non-Small Cell Lung Cancer Resistant or Refractory to Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. 258, doi. 10.1093/oncolo/oyac253
- By:
- Publication type:
- Article
Using Tumor-Informed Circulating Tumor DNA (ctDNA)-Based Testing for Patients with Anal Squamous Cell Carcinoma.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. 220, doi. 10.1093/oncolo/oyac249
- By:
- Publication type:
- Article
Optimization of Radium-223 Treatment of Castration-resistant Prostate Cancer Based on the Burden of Skeletal Metastasis and Clinical Parameters.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. 246, doi. 10.1093/oncolo/oyac245
- By:
- Publication type:
- Article
Duration of Chemotherapy-induced Nausea and Vomiting (CINV) as a Predictor of Recurrent CINV in Later Cycles.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. 208, doi. 10.1093/oncolo/oyac240
- By:
- Publication type:
- Article
Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. 239, doi. 10.1093/oncolo/oyac236
- By:
- Publication type:
- Article
Comparison of Four Clinical Prognostic Scores in Patients with Advanced Gastric and Esophageal Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. 214, doi. 10.1093/oncolo/oyac235
- By:
- Publication type:
- Article
Morphine Versus Oxycodone for Cancer Pain Using a Catechol-O-methyltransferase Genotype Biomarker: A Multicenter, Randomized, Open-Label, Phase III Clinical Trial (RELIEF Study).
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. 278, doi. 10.1093/oncolo/oyac233
- By:
- Publication type:
- Article
Health Care Utilization and Costs in Systemic Therapies for Metastatic Melanoma from 2016 to 2020.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. 268, doi. 10.1093/oncolo/oyac219
- By:
- Publication type:
- Article
Black Patients with Metastatic Castrate-Resistant Prostate Cancer Have a Shorter Time Interval Between PSA and Clinical Progression on Novel Hormonal Therapies plus Avelumab.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. 276, doi. 10.1093/oncolo/oyac203
- By:
- Publication type:
- Article